The QUALITY BY DESIGN APPROACH FOR SIMULTANEOUS DETERMINATION OF FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

QUALITY BY DESIGN APPROACH FOR SIMULTANEOUS DETERMINATION OF FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

  • Pankaj Kulkarni Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, India 431004
  • C.K.Jadhav Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, India 431004
  • Alaknanda M. Dodake-Supekar Department of Chemistry, S.B.E.S.College of science, Aurangpura, Aurangabad, Maharashtra, India 431001
  • Charansingh H Gill Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, India 431004

Abstract

ABSTRACT


Objective: To develop and validate a novel and simple reverse phase Ultra Performance Liquid Chromatography (UPLC) method for simultaneous determination of Fluticasone Propionate and Salmeterol Xinafoate from pharmaceutical finished product, applying Quality by design (QbD) approach.


Methods: The proposed analytical method developed and validated in a linear gradient condition at a flow rate of 0.40 mL/min over Waters ACQUITY BEH Shield RP 18, 2.1*100 mm, 1.7µm column by maintaining column oven temperature at 30°C and Sample cooler temperature at 15°C. Chromatograms monitored and recorded at 215 nm.


Results: The proposed method has been validated as per International Conference on Harmonization (ICH) guidelines with respect to system suitability, specificity, precision, linearity, accuracy, range, solution stability and robustness. This method is qualified in all parameters in case of system suitability and specificity; precision observed within the limit of 2.0%, excellent linear response observed with correlation coefficient (R2) for Salmeterol 0.99999 and Fluticasone Propionate 0.99999, for Accuracy within the limit of 98% to 102%.


Conclusion: A selective, suitable and accurate reverse phase UPLC method for simultaneous Determination of Fluticasone Propionate and Salmeterol Xinafoate in pharmaceutical finished product has been developed and validated successfully.

Keywords: Keywords: Gradient, ICH, UPLC, QbD and Validation.

References

REFERENCES
[1] https://emedicine.medscape.com/article/296301-overview .
[2] C.H.Gill, P.N.Kulkarni, A.S.Nipte, C.K.Jadhav, A.V.Chate, A.M.Dodake-Supekar, A study of method development and validation for estimation of Azelastine hydrochloride in nasal spray formulations by RP-HPLC method. Journal of Drug Delivery and Therapeutics 2018. 8, 6-s 236-240.
[3] https://www.rxwiki.com/fluticasone-propionate .
[4] https://en.wikipedia.org/wiki/Salmeterol .
[5] http://www.uspbpep.com/usp29/v29240/usp29nf24s0_m34220.html
[6] https://www.drugfuture.com/pharmacopoeia/usp35/data/v35300/usp35nf30s0_m74389.html
[7] André R. Sá COUTO, Daniela Espinha CARDOSO, Helena Maria CABRAL-MARQUES, Validation of an HPLC Analytical Method for the Quantitative/Qualitative Determination of Fluticasone Propionate in Inhalation Particles on Several Matrices. Scientia Pharmaceutica, 2014; 82: 787-797
[8]Ahmed Samir, Hesham Salem, Mohammad Abdelkawy, New developed spectroscopic method for simultaneous determination of Salmeterol Xinafoate and Fluticasone Propionate in bulk powder and Seritide discus inhalation. Bulletin of Faculty Pharmacy, Cairo University 2012 (50), 121-126.
[9] P. S. Jain, A. P. Gorle, S. S. Patil, R. S. Chavan, P. R. Bari, S. J. Surana, Stability-indicating RP-HPLC Method for Estimation of Salmeterol xinafoate in Bulk and in Pharmaceutical Formulation. International journal of Pharmaceutical Chemistry and Analysis, January – March 2015.2(1), 28-33.
[10] M SHAHANAZ, N.M.VAGEESH, N.D.NIZAMUDDIN *, B B HAZRA, DEVELOPMENT AND VALIDATION OF A RP-HPLC PDA METHOD FOR SIMULTANEOUS DETERMINATION OF FLUTICASONE AND SALMETEROL IN BULK AND PHARMACEUTICAL DOSAGE FORM. Innovat International Journal Of Medical & Pharmaceutical Sciences, 2018. 3(1)
[11] V.G.Nayak, S.G.Belapure, C.D.Gaitonde, A.A.Sule, Determination of salmeterol in metered-dose and dry-powder inhalers by reversed-phase high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis, February 1996, Volume 14, Issue 4, 511-513
[12] B. Prathap, S. Jegannath, K. V. Swathikrishna, V. Priyanka1, G. Rajeshwari, P. Gobalakrishnan, METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF AZELASTINE AND FLUTICASONE IN PHARMACEUTICAL DOSAGE FORM BY RP-HPLC. Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry, 4(2), 2016, 79-87.
[13] International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Pharmaceutical development Q8(R2); 2009.
[14] Pankaj N. Kulkarni, Alaknanda M. Dodake-Supekar, A. S. Nipte, C. K. Jadhav, Charansingh H. Gill, Analytical Method Development and Validation for Anti Asthmatic Drug Oxymetazoline Hydrochloride in Nasal Spray Formulations by RP-HPLC Journal of Drug Delivery and Therapeutics. 2019; 9(4-A):505-510.
[15] International Conference on Harmonization ICH-Q2 (R1), Guideline on Validation of Analytical Procedure: Text and Methodology, 2005.
[16] Lloyd R. Snyder, Joseph J. Kirkland, Joseph L. Glajch. Practical HPLC method development, second edition, 1997.
[17] SADC Guideline for stability testing, 2004.
[18] https://www.waters.com/waters/enIN/ACQUITY-UPLC-PDADetector/nav.htm?locale=enIN&cid= 514225
Statistics
17 Views | Downloads
How to Cite
Kulkarni, P., Jadhav, C., Dodake-Supekar, A., & Gill, C. (2020). The QUALITY BY DESIGN APPROACH FOR SIMULTANEOUS DETERMINATION OF FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE. International Journal of Applied Pharmaceutics, 12(4). Retrieved from https://innovareacademics.in/journals/index.php/ijap/article/view/37574
Section
Original Article(s)